Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of the fiscal period ended Tuesday, March 31, 2026.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2026 (2026-03-31): -195.33%.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-155.63%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-139.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-128.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-118.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-95.70%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-85.44%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Achieve Life Sciences, Inc.
Market Cap
$721.69M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-155.63%
3Y Avg
-139.03%
5Y Avg
-128.07%
Market Cap
$723.18M
Return on Invested Capital (ROIC)
-36.83%
TTM Avg
-41.75%
3Y Avg
-59.42%
5Y Avg
-51.49%
Market Cap
$714.37M
Return on Invested Capital (ROIC)
-19.45%
TTM Avg
-59.05%
3Y Avg
-125.75%
5Y Avg
-106.53%
Market Cap
$709.65M
Return on Invested Capital (ROIC)
6.11%
TTM Avg
9.98%
3Y Avg
8.97%
5Y Avg
8.63%
Market Cap
$702.82M
Return on Invested Capital (ROIC)
-47.96%
TTM Avg
-47.20%
3Y Avg
-41.20%
5Y Avg
-37.18%
Market Cap
$742.70M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$747.61M
Return on Invested Capital (ROIC)
-38.92%
TTM Avg
-31.45%
3Y Avg
-27.82%
5Y Avg
-24.27%
Market Cap
$694.79M
Return on Invested Capital (ROIC)
-12.00%
TTM Avg
-7.53%
3Y Avg
-5.45%
5Y Avg
-2.27%
Market Cap
$693.61M
Return on Invested Capital (ROIC)
-42.94%
TTM Avg
-42.70%
3Y Avg
-94.89%
5Y Avg
-93.87%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Achieve Life Sciences, Inc. (ACHV) | $721.69M | N/A | -155.63% | -139.03% | -128.07% |
| Candel Therapeutics, Inc. (CADL)vs › | $723.18M | -36.83% | -41.75% | -59.42% | -51.49% |
| Avalo Therapeutics, Inc. (AVTX)vs › | $714.37M | -19.45% | -59.05% | -125.75% | -106.53% |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $709.65M | 6.11% | 9.98% | 8.97% | 8.63% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $702.82M | -47.96% | -47.20% | -41.20% | -37.18% |
| Apnimed, Inc. (APMD)vs › | $742.70M | N/A | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $747.61M | -38.92% | -31.45% | -27.82% | -24.27% |
| Cytek Biosciences, Inc. (CTKB)vs › | $694.79M | -12.00% | -7.53% | -5.45% | -2.27% |
| Wave Life Sciences Ltd. (WVE)vs › | $693.61M | -42.94% | -42.70% | -94.89% | -93.87% |
| Faeth Therapeutics, Inc. (FTH)vs › | $693.19M | -110.62% | -99.41% | -74.42% | -73.36% |
ROIC
N/A
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-03-31 | -195.33% |
| 2025-12-31 | -150.72% |
| 2025-09-30 | -120.28% |
| 2025-06-30 | -97.17% |
| 2025-03-31 | -214.64% |
| 2024-12-31 | -122.28% |
| 2024-09-30 | -75.88% |
| 2024-06-30 | -42.36% |
| 2024-03-31 | -37.02% |
| 2023-12-31 | -179.04% |
| 2023-09-30 | -166.51% |
| 2023-06-30 | -156.25% |
| 2023-03-31 | -249.89% |
| 2022-12-31 | -166.92% |
| 2022-09-30 | -220.46% |
| 2022-06-30 | -108.67% |
| 2022-03-31 | -88.34% |
| 2021-12-31 | -77.02% |
| 2021-09-30 | -88.41% |
| 2021-06-30 | -67.88% |
| 2021-03-31 | -64.28% |
| 2020-12-31 | -39.48% |
| 2020-09-30 | -51.37% |
| 2020-06-30 | -89.82% |
| 2020-03-31 | -91.79% |
| 2019-12-31 | -90.12% |
| 2019-09-30 | -202.44% |
| 2019-06-30 | -140.03% |
| 2019-03-31 | -148.93% |
| 2018-12-31 | -80.68% |
| 2018-09-30 | -90.50% |
| 2018-06-30 | -72.70% |
| 2018-03-31 | -199.74% |
| 2017-12-31 | -159.82% |
| 2017-09-30 | -138.16% |
| 2017-06-30 | -127.65% |
| 2017-03-31 | -125.84% |
| 2016-12-31 | -106.79% |
| 2016-09-30 | -76.19% |
| 2016-06-30 | -67.00% |
| 2016-03-31 | -53.01% |
| 2015-12-31 | -49.95% |
| 2015-09-30 | -56.42% |
| 2015-06-30 | -78.23% |
| 2015-03-31 | -80.27% |
| 2014-12-31 | -79.08% |
| 2014-09-30 | -65.92% |
| 2014-06-30 | -112.35% |
| 2014-03-31 | -106.24% |
| 2013-12-31 | -86.68% |
| 2013-09-30 | -68.53% |
| 2013-06-30 | -53.13% |
| 2013-03-31 | -41.36% |
| 2012-12-31 | -33.83% |
| 2012-09-30 | -36.70% |
| 2012-06-30 | -29.16% |
| 2012-03-31 | -26.78% |
| 2011-12-31 | -59.86% |
| 2011-09-30 | -20.50% |
| 2011-06-30 | -36.93% |
| 2011-03-31 | -28.71% |
| 2010-12-31 | -23.12% |
| 2010-09-30 | -16.67% |
| 2010-06-30 | -3.46% |
| 2010-03-31 | -7.76% |
| 2009-12-31 | -5.54% |
| 2009-09-30 | -111.99% |
| 2009-06-30 | -246.26% |
| 2009-03-31 | -140.27% |
| 2008-12-31 | -127.16% |
| 2008-09-30 | -54.09% |
| 2008-06-30 | -42.15% |
| 2008-03-31 | -45.04% |
| 2007-12-31 | -39.18% |
| 2007-09-30 | -82.72% |
| 2007-06-30 | -66.32% |
| 2007-03-31 | -54.68% |
| 2006-12-31 | -54.09% |
| 2006-09-30 | -39.71% |
| 2006-06-30 | -38.08% |
| 2006-03-31 | -55.96% |
| 2005-12-31 | -46.70% |
| 2005-09-30 | -122.20% |
| 2005-06-30 | -171.59% |
| 2005-03-31 | -122.07% |
| 2004-12-31 | -85.47% |
| 2004-09-30 | -56.01% |
| 2004-06-30 | -44.85% |
| 2004-03-31 | -70.50% |
| 2003-12-31 | -54.33% |
| 2003-09-30 | -49.29% |
| 2003-06-30 | -106.14% |
